The innate oxygen dependant immune pathway as a sensitive parameter to predict the performance of biological graft materials

Biomaterials

Volumn 33, Issue 27, 2012, Pages 6380-6392

  Bryan, Nicholas ^a   Ashwin, Helen ^b   Smart, Neil ^c   Bayon, Yves ^b   Scarborough, Nelson ^b   Hunt, John A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b MEDTRONIC INC   (United States)

^c ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

Acute inflammation; Biomaterial; Chemiluminescence; In Vitro; Neutrophil; Reactive oxygen species

Indexed keywords

ACUTE INFLAMMATION; ALLODERM; CHEMILUMINESCENCE ASSAY; CLINICAL PERFORMANCE; DOWN-STREAM; GRAFT MATERIALS; GRAFT REJECTION; HEALTHY HUMANS; IN-VITRO; IN-VIVO; NEUTROPHIL; PHOTOPROTEINS; REACTIVE OXYGEN SPECIES; SENSITIVE PARAMETER; SURGICAL MATERIALS; WHOLE BLOOD;

CHEMILUMINESCENCE; OXYGEN; PATHOLOGY; SURGERY; TISSUE;

BIOMATERIALS;

ADJUVANT K; BIOMATERIAL; PHOLASIN; PHOTOPROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CHEMICAL MODIFICATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS LINKING; DERMIS; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; INCUBATION TIME; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; MALE; NONHUMAN; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; RAT; SURGICAL EQUIPMENT; VALIDATION PROCESS;

ADULT; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; CELLS, CULTURED; HUMANS; IMMUNITY, INNATE; LEUKOCYTES; LUMINESCENT MEASUREMENTS; MATERIALS TESTING; MICROSCOPY, CONFOCAL; OXYGEN; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STAINING AND LABELING; SUS SCROFA; TIME FACTORS; TISSUE DONORS; TRANSPLANTS; WOUND HEALING;

EID: 84863566335     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.05.058     Document Type: Article

References (41)

1. Witko-Sarasat V., Rieu P., Descamps-Latscha B., Lesavre P., Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000, 80:617-653.
2. Segel A.W. How neutrophils kill microbes. Annu Rev Immunol 2005, 23:197-223.
3. 2O reveals a human neutrophil lifespan of 5.4 days. Blood 2010, 116:625-627.
4. 2 signals to leukocytes. Curr Biol 2009, 19:R553-R555.
5. Rutault K., Alderman C., Chain B.M., Katz D.R. Reactive oxygen species activate peripheral blood dendritic cells. FRBM 1999, 26:232-238.
6. Kraaij M.D., Savage N.D.L., van der Kooij S.W., Koekkoek K., Wang J., van den Berg J.M., et al. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. PNAS 2010, 107:17686-17691.
7. Gutteridge J.M.C., Paterson S.K., Sega A.W., Halliwell B. Inhibition of lipid peroxidation by the iron-binding protein lacroferrin. J Biochem 1981, 199:259-261.
8. Goetz D.H., Holmes M.A., Borregaard N.M., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a gacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002, 10:1033-1043.
9. Wossner J.F. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB 1991, 5:2145-2154.
10. Nathan C., Shiloh M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and bacterial pathogens. PNAS 2000, 97:8841-8848.
11. Levy O. Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes. J Leukoc Biol 2004, 76:909-925.
12. Butterfield T.A., Best T.M., Merrick M.A. The dual roles of neutrophils and macrophages in inflammation: a critical balance between tissue damage and repair. J Athl Train 2006, 4:457-465.
13. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006, 6:175-182.
14. Segel G.B., Halterman M.W., Lichtman M.A. The paradox of the neutrophil's role in tissue injury: a review. J Leukoc Biol 2011, 89:1-14.
15. Lam G.Y., Huang J., Brumell J.H. The many roles of NOX2 NADPH oxidase-derived ROS in immunity. Semin Immunopath 2010, 32:415-430.
16. Marin D.P., Bolin A.P., Macedo R.C.S., Samaio S.C., Otton R. ROS production in neutrophils from allovan-Induced diabetic rats treated in vivo with astaxanthin. Int Immunopharmacol 2011, 11:103-109.
17. Naik E., Dixit V.M. Mitcohondrial reactive oxygen species drive proinflammatory cytokine production. JEM 2011, 208:417-420.
18. Liu W.F., Ma M., Bratlie K.M., Dang T.T., Langer R., Anderson D.G. Real-time in vivo detection of biomaterial-induced reactive oxygen species. Biomaterials 2011, 32:1796-1801.
19. Kader K.N., Coyle C.H. Reactive oxygen and nitrogen species: implications for cardiovascular tissue device engineering. J Biomed Mater Res Part B 2007, 83B:138-144.
20. Cheung C.Y., McCartney S.J., Anseth K.S. Synthesis of polymerizable superoxide dismutase mimetics to reduce reactive oxygen species damage in transplanted biomedical devices. Adv Funct Mater 2008, 18:3119-3126.
21. Sutherland K., Mahoney J.R., Coury A.J., Eaton J.W. Degradation of biomaterials by phagocyte-derived oxidants. J Clin Invest 1993, 92:2360-2367.
22. Shah B.C., Tiwari M.M., Goede M.R., Eichler M.J., Hollins R.R., McBride C.L., et al. Not all biologics are equal!. Hernia 2011, 15:165-171.
23. Lieberman M., Sachanandani D.M., Pinney C.A. Comparative study of neutrophil activation by chemiluminescence and flow cytometry. Clin Diag Lab Immun 1996, 3:654-662.
24. Knight J. The piddock and the immunologist. Immunol News 1997, 4(1):26-31.
25. ® with peroxidases and hypochlorus acid. FRBM 2000, 28:1555-1563.
26. Muller T., Davies E.V., Campbell A.K. Pholasin chemiluminescence detects mostly superoxide anion released from activated human neutrophils. J Biolum Chemilum 1989, 3:105-113.
27. Knight J., McCafferty A., Noon E., Bell A. Indirect evidence to support the production of hydroxyl and/or ferryl radicals at sites of inflammation. Brit J Rheumatol 1996, 35(Abst suppl. 2).
28. Glebska J., Koppenol W.H. Chemiluminescence of pholasin caused by peroxynitrite. FRBM 2005, 38:1014-1022.
29. Reichl S., Vocks A., Petkovic M., Schiller J., Arnhold J. The photoprotein pholasin as a luminescence substrate for detection of superoxide anion radicals and myeloperoxidase activity in stimulated neutrophils. Free Radic Res 2001, 35:723-733.
30. Potnis P.A., Tesfamariam B., Wood S.C. Induction of nicotinamide-adenine dinucleotide phosphate oxidase and apoptosis by biodegradable polymers in macrophages: implications for stents. J Cardiovasc Pharmacol 2011, 57:712-720.
31. Crossley L.J. Neutrophil activation by fMLP regulates FOXO (forkhead) transcription factors by multiple pathways, one of which includes the binding of FOXO to the survival factors Mcl-1. J Leukoc Biol 2003, 74:583-592.
32. 2 toxicity. Inflammation 1980, 4:371-380.
33. Gavella M., Kveder M., Lipovac V. Modulation of ROS production in human leukocytes by ganglioside micelles. Braz J Med Biol Res 2010, 43:942-949.
34. Walton J.R., Bowman N.K., Khatib Y., Linklater J., Murrell G.A.C. Restore orthobiologic implant: not recommended for augmentation of rotator cuff repair. J Bone Jt Surg Am 2007, 89:786-791.
35. Malcarney H.L., Bonar F., Murrell G.A.C. Early inflammatory reaction after rotator cuff repair with a porcine small intestinal submucosal implant. Am J Sports Med 2005, 33:907-911.
36. Valentin J.E., Badylak J.S., McCabe G.P., Badylak S.F. Extracellular matrix bioscaffolds for orthopaedic applications. a comparative histologic Study. J Bone Jt Surg Am 2006, 88:2673-2686.
37. Shallberger S.P., Stanley B.J., Hauptman J.G., Steficek B.A. Effect of porcine small intestinal submucosa on acute full-thickness wounds in dogs. Vet Surg 2008, 38:515-524.
38. Orenstein S.B., Qiao Y., Kaur M., Klueh U., Kreutzer D.L., Novitsky Y.W. Human monocyte activation by biologic and biodegradable meshes in vitro. J Surg Endosc 2010, 24:805-811.
39. Orenstein S.B., Qiao Y., Klueh U., Kreutzer D.L., Novitsky Y.W. Activation of human mononuclear cells by porcine biologic meshes in vitro. Hernia 2010, 14:401-407.
40. Orenstein S., Qiao Y., Kaur M., Klueh U., Kreutzer D., Novitsky Y. In vitro activation of human peripheral blood mononuclear cells induced by human biologic meshes. J Surg Res 2010, 158:10-14.
41. Bryan N., Rhodes N.P., Hunt J.A. Derivation and performance of an entirely autologous injectable hydrogel delivery system for cell-based therapies. Biomaterials 2009, 30:180-188.